10.56
price up icon11.16%   1.06
after-market Handel nachbörslich: 10.65 0.09 +0.85%
loading
Schlusskurs vom Vortag:
$9.50
Offen:
$9.59
24-Stunden-Volumen:
3.96M
Relative Volume:
1.52
Marktkapitalisierung:
$649.92M
Einnahmen:
$3.64M
Nettoeinkommen (Verlust:
$-87.37M
KGV:
-2.5693
EPS:
-4.11
Netto-Cashflow:
$-86.46M
1W Leistung:
+14.41%
1M Leistung:
+75.71%
6M Leistung:
+78.98%
1J Leistung:
+332.79%
1-Tages-Spanne:
Value
$9.5298
$10.63
1-Wochen-Bereich:
Value
$8.96
$10.63
52-Wochen-Spanne:
Value
$2.34
$10.63

Verastem Inc Stock (VSTM) Company Profile

Name
Firmenname
Verastem Inc
Name
Telefon
(781) 292-4200
Name
Adresse
117 KENDRICK STREET, NEEDHAM, MA
Name
Mitarbeiter
78
Name
Nächster Verdiensttermin
2024-11-06
Name
Neueste SEC-Einreichungen
Name
VSTM's Discussions on Twitter

Vergleichen Sie VSTM mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
VSTM
Verastem Inc
10.56 567.45M 3.64M -87.37M -86.46M -4.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Verastem Inc Stock (VSTM) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-10 Eingeleitet Jefferies Buy
2025-03-24 Bestätigt H.C. Wainwright Buy
2024-12-31 Bestätigt BTIG Research Buy
2024-09-30 Eingeleitet Guggenheim Buy
2023-11-21 Fortgesetzt BTIG Research Buy
2023-09-27 Eingeleitet B. Riley Securities Buy
2023-06-15 Hochstufung Mizuho Neutral → Buy
2022-09-07 Fortgesetzt Alliance Global Partners Buy
2022-04-29 Fortgesetzt Cantor Fitzgerald Overweight
2022-04-14 Eingeleitet RBC Capital Mkts Outperform
2022-03-09 Eingeleitet Truist Buy
2021-07-01 Eingeleitet Alliance Global Partners Buy
2021-05-24 Hochstufung BTIG Research Neutral → Buy
2019-06-20 Herabstufung BTIG Research Buy → Neutral
2019-05-10 Herabstufung Raymond James Outperform → Mkt Perform
2018-07-13 Eingeleitet BTIG Research Buy
2018-05-02 Eingeleitet Seaport Global Securities Buy
2018-03-08 Eingeleitet B. Riley FBR, Inc. Buy
2017-09-07 Bestätigt H.C. Wainwright Buy
2017-04-13 Eingeleitet Oppenheimer Outperform
2017-03-24 Bestätigt H.C. Wainwright Buy
2015-09-29 Herabstufung Cantor Fitzgerald Buy → Hold
2015-09-29 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2015-09-29 Herabstufung Jefferies Buy → Hold
2015-09-29 Herabstufung Raymond James Strong Buy → Outperform
2015-09-28 Herabstufung Mizuho Buy → Neutral
2015-09-28 Herabstufung ROTH Capital Buy → Neutral
2015-09-09 Eingeleitet Raymond James Strong Buy
2015-05-12 Bestätigt UBS Buy
2015-04-08 Eingeleitet H.C. Wainwright Buy
2015-01-23 Bestätigt ROTH Capital Buy
2014-07-08 Fortgesetzt Oppenheimer Perform
2014-02-11 Eingeleitet Mizuho Buy
Alle ansehen

Verastem Inc Aktie (VSTM) Neueste Nachrichten

pulisher
Sep 03, 2025

What are analysts’ price targets for Verastem Inc.Weekly Trading Summary & Safe Entry Point Alerts - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Combining price and volume data for Verastem Inc.July 2025 Chart Watch & Advanced Technical Analysis Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Ranking Verastem Inc. among high performing stocks via toolsWeekly Trade Recap & High Accuracy Investment Entry Signals - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Verastem Inc. stock momentum explainedBond Market & Verified Momentum Stock Watchlist - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What earnings revisions data tells us about Verastem Inc.Earnings Risk Report & Verified Swing Trading Watchlists - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Trend analysis for Verastem Inc. this weekTrade Risk Summary & Detailed Earnings Play Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Market reaction to Verastem Inc.’s recent news2025 Market Sentiment & Real-Time Stock Price Movement Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can Verastem Inc. recover in the next quarterWeekly Trend Summary & Long-Term Capital Growth Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Comparing Verastem Inc. in custom built stock radars2025 Trade Ideas & Stock Portfolio Risk Management - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Earnings visualization tools for Verastem Inc.Weekly Market Summary & Free Safe Entry Trade Signal Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using AI based signals to follow Verastem Inc.2025 Volatility Report & Fast Entry High Yield Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Chart based exit strategy for Verastem Inc.2025 Price Targets & Risk Controlled Daily Plans - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Verastem Inc. Approaches Psychological Resistance LevelNew Guidance & Free Safe Entry Trade Signal Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

How to use a screener to detect Verastem Inc. breakoutsTrade Performance Summary & Low Risk Investment Opportunities - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Earnings Report: Is Verastem Inc. stock risky to hold now2025 Trading Volume Trends & Consistent Profit Alerts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Is Verastem Inc. stock poised for growthShare Buyback & Detailed Earnings Play Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What is Verastem Inc.’s valuation compared to sector2025 Key Lessons & Capital Efficiency Focused Ideas - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Can Verastem Inc. rally from current levelsChart Signals & Proven Capital Preservation Tips - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Can trapped investors hope for a rebound in Verastem Inc.Entry Point & AI Forecasted Entry/Exit Points - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Will Verastem Inc. benefit from macro trends2025 Institutional Moves & Accurate Entry/Exit Alerts - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Can Verastem Inc. deliver alphaWeekly Earnings Recap & Weekly Top Stock Performers List - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Is this a good reentry point in Verastem Inc.2025 Investor Takeaways & Safe Capital Growth Stock Tips - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Why did VSTM's Q4 2024 EPS miss forecasts so drastically? - AInvest

Sep 01, 2025
pulisher
Sep 01, 2025

Will Verastem Inc. continue its uptrend2025 Technical Overview & Low Drawdown Trading Strategies - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

What earnings revisions data tells us about Verastem IncTrade Exit Summary & Low Risk High Win Rate Picks - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using R and stats models for Verastem Inc. forecasting2025 Market Overview & Weekly High Potential Stock Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is now a turning point for Verastem Inc.Weekly Trade Summary & Daily Volume Surge Signals - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Are Bears Losing Grip on Verastem Inc. getLinesFromResByArray error: size == 0 - kangso.co.kr

Aug 31, 2025
pulisher
Aug 31, 2025

Chart overlay techniques for tracking Verastem Inc.Market Growth Report & Safe Capital Growth Tips - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Using Python tools to backtest Verastem Inc. strategies2025 EndofYear Setup & Free Expert Verified Stock Movement Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Verastem Inc. stock trend outlook and recovery pathRisk Management & Stepwise Trade Signal Implementation - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Can Verastem Inc. stock double in the next year getLinesFromResByArray error: size == 0 - 클래시안

Aug 31, 2025
pulisher
Aug 31, 2025

Is It Too Early to Call Recovery in Verastem Inc. getLinesFromResByArray error: size == 0 - 클래시안

Aug 31, 2025

Finanzdaten der Verastem Inc-Aktie (VSTM)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Verastem Inc-Aktie (VSTM) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Paterson Dan
President and CEO
Jun 20 '25
Sale
5.13
17,808
91,355
443,839
Calkins Daniel
Chief Financial Officer
Jun 20 '25
Sale
5.13
4,110
21,084
109,945
Calkins Daniel
Chief Financial Officer
Jun 23 '25
Sale
4.71
25
118
109,920
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):